INSM · INSMED Inc
$123.74
-2.59 (-2.05%)
At close · Aug 14
Market Cap
$27.02B
Shares
218.38M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding INSM
733 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| JPMorgan Large Cap Growth Fund | — | 10,633,939 | $1,738,861,705 | 1.62% | Long | 2026-03-31 | |
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 6,850,260 | $1,120,154,515 | 0.06% | Long | 2026-03-31 | |
| Invesco QQQ Trust, Series 1 | QQQ | 4,540,817 | $742,514,396 | 0.20% | Long | 2026-03-31 | |
| Growth Fund of America | — | 6,254,890 | $668,710,290 | 0.19% | Long | 2026-05-31 | |
| VANGUARD SMALL-CAP INDEX FUND | — | 2,485,062 | $406,357,338 | 0.25% | Long | 2026-03-31 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 2,380,795 | $389,307,598 | 0.48% | Long | 2026-03-31 | |
| VANGUARD MID-CAP INDEX FUND | — | 2,327,576 | $380,605,228 | 0.19% | Long | 2026-03-31 | |
| iShares Biotechnology ETF | — | 1,587,887 | $259,651,282 | 3.20% | Long | 2026-03-31 | |
| JPMorgan Mid Cap Growth Fund | — | 1,549,913 | $253,441,774 | 2.22% | Long | 2026-03-31 | |
| VANGUARD GROWTH INDEX FUND | — | 1,526,740 | $249,652,525 | 0.08% | Long | 2026-03-31 | |
| JPMorgan Growth Advantage Fund | — | 1,504,495 | $246,015,022 | 1.22% | Long | 2026-03-31 | |
| VANGUARD SMALL-CAP GROWTH INDEX FUND | — | 1,390,446 | $227,365,730 | 0.59% | Long | 2026-03-31 | |
| iShares Russell Mid-Cap Growth ETF | — | 1,316,972 | $215,351,261 | 1.15% | Long | 2026-03-31 | |
| Fidelity Contrafund | — | 908,349 | $148,533,228 | 0.09% | Long | 2026-03-31 | |
| SMALLCAP World Fund Inc | — | 856,070 | $139,984,566 | 0.17% | Long | 2026-03-31 | |
| Strategic Advisers Fidelity U.S. Total Stock Fund | — | 1,260,807 | $134,792,876 | 0.05% | Long | 2026-05-31 | |
| VANGUARD MID-CAP GROWTH INDEX FUND | — | 819,756 | $134,046,501 | 0.46% | Long | 2026-03-31 | |
| iShares Russell Mid-Cap ETF | — | 801,022 | $130,983,117 | 0.27% | Long | 2026-03-31 | |
| Artisan Mid Cap Fund | — | 793,310 | $129,722,051 | 4.39% | Long | 2026-03-31 | |
| iShares Russell 1000 Growth ETF | — | 791,377 | $129,405,967 | 0.12% | Long | 2026-03-31 | |
| Growth Fund | — | 759,530 | $124,198,346 | 0.25% | Long | 2026-03-31 | |
| Select Biotechnology Portfolio | — | 1,109,201 | $118,584,679 | 2.25% | Long | 2026-05-31 | |
| Fidelity Extended Market Index Fund | — | 1,098,781 | $117,470,677 | 0.27% | Long | 2026-05-31 | |
| JPMorgan Active Growth ETF | — | 710,127 | $116,119,967 | 1.42% | Long | 2026-03-31 | |
| T. Rowe Price Health Sciences Fund, Inc. | — | 702,695 | $114,904,686 | 1.05% | Long | 2026-03-31 | |
| Franklin Dynatech Fund | — | 700,000 | $114,464,000 | 0.46% | Long | 2026-03-31 | |
| Bridge Builder Small/Mid Cap Growth Fund | — | 661,620 | $108,188,102 | 1.17% | Long | 2026-03-31 | |
| Fidelity Mid Cap Index Fund | — | 775,652 | $105,744,637 | 0.21% | Long | 2026-04-30 | |
| State Street(R) SPDR(R) S&P(R) Biotech ETF | — | 607,845 | $99,394,814 | 1.34% | Long | 2026-03-31 | |
| Invesco NASDAQ 100 ETF | — | 915,980 | $97,927,422 | 0.10% | Long | 2026-05-31 | |
| Fidelity Advisor Growth Opportunities Fund | — | 905,400 | $96,796,314 | 0.27% | Long | 2026-05-31 | |
| Heritage Fund | — | 708,677 | $96,613,935 | 1.80% | Long | 2026-04-30 | |
| T. Rowe Price New Horizons Fund, Inc. | — | 590,148 | $96,501,001 | 0.76% | Long | 2026-03-31 | |
| VANGUARD EXPLORER FUND | — | 705,654 | $96,201,810 | 0.44% | Long | 2026-04-30 | |
| Fidelity Puritan Fund | — | 848,933 | $90,759,427 | 0.27% | Long | 2026-05-31 | |
| VIP Growth Portfolio | — | 452,933 | $74,063,604 | 0.70% | Long | 2026-03-31 | |
| JNL/JPMorgan MidCap Growth Fund | — | 426,266 | $69,703,016 | 2.24% | Long | 2026-03-31 | |
| VANGUARD HEALTH CARE INDEX FUND | — | 640,424 | $68,467,730 | 0.36% | Long | 2026-05-31 | |
| Fidelity Advisor Biotechnology Fund | — | 489,600 | $66,747,168 | 3.51% | Long | 2026-04-30 | |
| Carillon Eagle Mid Cap Growth Fund | — | 391,484 | $64,015,464 | 1.34% | Long | 2026-03-31 | |
| Fidelity Growth Company Fund | — | 566,421 | $60,556,069 | 0.06% | Long | 2026-05-31 | |
| Eventide Healthcare & Life Sciences Fund | — | 367,183 | $60,041,764 | 3.78% | Long | 2026-03-31 | |
| Artisan Global Opportunities Fund | — | 362,740 | $59,315,245 | 3.89% | Long | 2026-03-31 | |
| Nomura Science and Technology Fund | — | 360,078 | $58,879,955 | 0.95% | Long | 2026-03-31 | |
| Columbia Acorn Fund | — | 336,411 | $55,009,927 | 2.45% | Long | 2026-03-31 | |
| Columbia Cornerstone Growth Fund | — | 399,807 | $54,505,688 | 0.85% | Long | 2026-04-30 | |
| Columbia Contrarian Core Fund | — | 506,797 | $54,181,667 | 0.29% | Long | 2026-05-31 | |
| Fidelity Advisor Equity Growth Fund | — | 501,912 | $53,659,412 | 0.40% | Long | 2026-05-31 | |
| Select Health Care Portfolio | — | 500,000 | $53,455,000 | 0.92% | Long | 2026-05-31 | |
| Fidelity OTC Portfolio | — | 384,000 | $52,350,720 | 0.13% | Long | 2026-04-30 |
Showing 1–50 of 733 positions
Key facts
CIK
1104506
CUSIP
457669307
13F (30d)
609 filings
602 filers
Visit website
Investor relations